Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by ronzon Mar 28, 2014 8:12pm
377 Views
Post# 22384550

RE:RE:RE:RE:RE:RE:Will knight take over Nuvo?

RE:RE:RE:RE:RE:RE:Will knight take over Nuvo?
consultant99, I thank-you for your interpretation of the possibility of a buy out, but I think that a few items are to be pointed out..... Firstly, lets base this as if the offer was on the table today. I don't think that we could expect too much from wf10 because it isn't close enough to market yet, although it is a great potential up and coming drug, it has a long way to go yet.Secondly, I think that we would be between 50 and 100 million dollars considering the economic times. Expecting any more than that just isnt realistic and given the recent company's track record, you would be hard pressed to make an argument to the contrary. Keep the values in realistic values, not hypatheticals, just the facts! 
Bullboard Posts